Medical Management of Pulmonary Hypertension: Calcium Channel Blockers Vs Sildenafil A Systematic Review
Abstract
Background: Pulmonary hypertension can be defined as incompatibility in blood pressure level into vessels and right side of heart is affected severely through this. As a result, heart failure among patients is common and reduction of blood flow affects negatively over respiratory rate. Calcium channel blockers such as Amlodipine, Nicardipine, Felodipin are potential to slow down blood pressure and accumulation of calcium ions are decreased in vessel wall. In addition, Sildenafil is an active Viagra component that also helps to regulate thickness of blood vessels for controlling pressure. This study mainly focuses on comparing medical management strategy of pulmonary hypertension by using Calcium channel blockers and Sildenafil. Methods: This study is actually a systemic review to analyse the impact of Calcium channel blockers and Sildenafil on patients suffering from pulmonary hypertension. Original full research articles are selected for literature review and 63 patients are detected for easy comparison of drug usage and facilities. Both of the drugs have been applied with 0.3 mg/kg dose for each of the sample population to understand hypertension crisis. All the demographic, postoperative and preoperative variables have been discussed promptly for acquiring proper knowledge. Results: The result has shown that Calcium channel blockers are better to treat pulmonary hypertension than Sildenafil by delivering no side effects on patients. On the other hand, therapeutic value of…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 63 participants or records.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.